Weeks 5 & 6
Midterm - End of Week 5
List of Boards and Beyond Videos along with length
Note: If you are logged into Board and Beyond, these links should go directly to the video.
This Week: 69 minutes
Recent review of new oral anticoagulants
Also on Case 9
--Read introduction, Pharmacology of NOACS, laboratory measurement, and NOAC reversal.
--(Pages E1-E8) Review Table 1 & Figure 1
--Rest of article is for reference as needed in the future.
Raval AN, Cigarroa JE, Chung MK, Diaz-Sandoval LJ, Diercks D, et al. Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association. Circulation. 2017 Mar 7;135(10):e604-e633. doi: 10.1161/CIR.0000000000000477.
See section on Anticoagulation RX and Table 1. Use rest for reference
Look at “Lung Cancer Stage Classification Eight Edition” in the Lung Cancer Guidelines Section
Konstantinides SV, Barco S, Lankeit M, Meyer G. Management of Pulmonary Embolism: An Update. J Am Coll Cardiol. 2016 Mar 1;67(8):976-90. doi:10.1016/j.jacc.2015.11.061.
Andexxa-An Antidote for Apixaban and Rivaroxaban. JAMA. 2018 Jul 24;320(4):399-400. doi: 10.1001/jama.2018.9257.
Note: also look closely on the ACCP guideline document for appropriate treatments and the staging document to understand this topic
Kanaji N, Watanabe N, Kita N, Bandoh S, Tadokoro A, Ishii T, Dobashi H, Matsunaga T. Paraneoplastic syndromes associated with lung cancer. World J Clin Oncol. 2014 Aug 10;5(3):197-223. doi: 10.5306/wjco.v5.i3.197.
Lung Cancer, Pulmonary Embolism (PE), and Pleural Diseases
HTML to Markdown conversion with Turndown by Dom Christie https://domchristie.github.io/turndown/ Source: https://guides.utmb.edu/cvp/case6 Captured on May 5, 2021